SVP and CFO Thomas R Staab II sold $49K of BioCryst Pharmaceuticals, Inc.

Sold$49,250

$9.85Price

5,000Shares

−4%Stake

What BCRX did after the filing

Prices for BCRX after this filing aren't in yet.

Traded Mon, Jan 28. Filed Wed, Jan 30, 4:10 PM ET, after the close. Not investment advice.